Archive for the ‘Life Sciences’ Category

Manufacturing Execution Systems in Drug Research and Development

Posted in Life Sciences, Operations Management on Wednesday, February 13th, 2019. No comments yet
Tags: , , , ,

The U.S. Food & Drug Administration (FDA) outlines the drug development process in five steps: Discovery and development Preclinical research Clinical trials FDA review FDA post-market safety monitoring I caught up with Emerson’s Zuwei Jin whom you may recall from earlier posts on the role of automation in the drug development process. Zuwei explained to […]

Biopharmaceutical Single Use Measurement and Control

Posted in Life Sciences on Friday, January 18th, 2019. No comments yet
Tags: , , ,

A recent Biopharm International article, Single-Use Bioprocessing Equipment Trends and Adoption by CMOs highlighted this trend: Single-use systems (SUS)—bioprocessing equipment designed for one-time use or a single product manufacturing campaign—has become the leading paradigm for pre-commercial (preclinical and clinical supplies) manufacturing of biopharmaceutical products (1). At this past autumn’s Emerson Exchange conference in San Antonio, […]

Fostering Organizational Collaboration in the Life Sciences

Posted in Life Sciences on Friday, January 11th, 2019. No comments yet
Tags: , , ,

As automation technologies continue to incorporate commercial off the shelf technologies and cybersecurity concerns grow, the need for manufacturers’ Information Technology (IT), Operational Technology (OT) and Quality teams to collaborate grows. In a PharmTech article, Improving Production: How IT, OT, and Quality Can Collaborate, Emerson’s Will Goetz and Ron Rossbach describe how the different groups […]

Outlook and Trends for Biotech Industry

Posted in Life Sciences on Wednesday, November 14th, 2018. No comments yet
Tags: , , , ,

What is the 2019 outlook for research & development in the biotech industry? Pharmaceutical Processing magazine explores this question in an article, Outlook 2019: Tech, Data, and Biotech Boom. Emerson’s Bob Lenich joined other suppliers to this industry to share his thoughts on some of the issues, challenges and developments expected to occur in the […]

Tracking Cell Therapy Chain of Identity

Posted in Life Sciences, Operations Management on Monday, November 5th, 2018. No comments yet
Tags: , , , ,

Cell therapy is when: …cellular material is injected into a patient;[1] this generally means intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy. For manufacturers in the Life Sciences industry, making these therapies poses challenges since each batch is specific to […]